GoodRx Holdings, Inc. (GDRX) Comparison with companies in other sectors?

GoodRx Holdings, Inc. has a share price of 357.17M. You can analyze GoodRx Holdings, Inc. (GDRX) competitors across different market sectors through stock heatmaps.

What are GDRX's NET and operating margins?

GoodRx Holdings, Inc. (GDRX) operating margin is around 0.10, and net profit margin is approximately 0.06 as of the latest reports.

In what way does GDRX's earnings per share (EPS) trend reflect its financial momentum?

GoodRx Holdings, Inc. (GDRX) EPS is 0.07 (If EPS value is positive, then “signals consistent profit growth” if Negative then “signals consistent loss”). This metric is also critical in assessing valuation metrics like the P/E ratio for GoodRx Holdings, Inc. is 71.43, and the company’s ability to reinvest or distribute profits.

What does a high ROE mean for GoodRx Holdings, Inc.?

A high ROE suggests efficient use of shareholder equity to generate profit. It often signals strong management and profitability.

How do I know if AAPL is overvalued or undervalued?

Check valuation ratios for GoodRx Holdings, Inc. like P/E which is 39.52, P/B which is 2.90, and PEG which is 0.82. Compare them with sector averages to evaluate if the stock is priced fairly.

GoodRx Holdings, Inc.

GDRX•NASDAQ

Healthcare

Medical - Healthcare Information Services

$5.00

$0.03(0.60%)

Fundamental Analysis of GoodRx Holdings, Inc. (GDRX)

Comprehensive financial metrics and ratios analysis

EPS (TTM)

$0.07

P/E Ratio

71.43

ROE

0.07%

Net Margin

0.06%

Key Financial Metrices

Valuation Metrics

4 metrics

Market CapTotal market value of outstanding shares

$1.79B

Shares OutstandingTotal number of shares issued

$357.17M

Book Value/ShareNet worth per share

$1.73

Revenue/ShareAnnual revenue per share

$2.10

Profitability Metrics

6 metrics

EPS (TTM)Earnings per share trailing twelve months

$0.07

Net MarginNet income as percentage of revenue

6.02%

Operating MarginOperating income as percentage of revenue

10.36%

ROEReturn on shareholders' equity

6.99%

ROAReturn on total assets

3.70%

ROCEReturn on capital employed

6.93%

Cash Flow Metrics

3 metrics

Free Cash Flow/ShareCash generated per share after capex

$0.27

Cash/ShareCash and equivalents per share

$0.79

FCF YieldFree cash flow as percentage of market cap

5.66%

Dividend Metrics

2 metrics

Dividend/ShareAnnual dividend payment per share

Dividend YieldAnnual dividend as percentage of stock price

Financial Ratios Analysis data is not available for GDRXFinancial Ratios Analysis details for GDRX are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Sector Benchmarking data is not available for GDRXSector Benchmarking details for GDRX are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Understanding Fundamental Analysis for GoodRx Holdings, Inc. Investment Decisions

What is Fundamental Analysis?

Fundamental analysis is a method used to assess the intrinsic value of GoodRx Holdings, Inc.. Using financial reports, management structure, competitive position, and market environment, investors can determine whether the stock is undervalued or overvalued. This analysis helps investors like you make more informed investment decisions, taking into account GoodRx Holdings, Inc.'s unique business strengths and challenges.

Key Financial Metrics for GoodRx Holdings, Inc.

For GoodRx Holdings, Inc., essential financial indicators include EPS 0.07, PE 71.43, and ROE 0.07. These key ratios reveal insights into GoodRx Holdings, Inc.'s profitability, valuation, and operational health. Understanding these metrics enables you to compare GoodRx Holdings, Inc. with its industry peers and decide whether it presents a viable investment opportunity.

Profitability and Operational Efficiency of GoodRx Holdings, Inc.

Metrics like Net Margin 6.02% and ROA 3.70% shed light on how well GoodRx Holdings, Inc. is generating profits. A high profitability ratio often indicates strong management and a solid business model, which are essential for long-term growth. These metrics are crucial in assessing whether GoodRx Holdings, Inc. can sustain its operations and continue growing in the future.

Valuation and Market Position of GoodRx Holdings, Inc.

Using ratios such as P/B Ratio 2.90 and PEG Ratio 0.82, investors can assess whether GoodRx Holdings, Inc. is appropriately valued based on its financials and growth potential. These figures, combined with GoodRx Holdings, Inc.'s market capitalization, give insight into its competitive positioning and investor expectations, helping you make informed decisions on pricing and value.

Financial Health and Risk Assessment for GoodRx Holdings, Inc.

Financial health indicators, such as Debt/Equity Ratio 0.08 and Cash Flow $0.27, provide a snapshot of GoodRx Holdings, Inc.'s ability to meet financial obligations and handle economic setbacks. A company with a strong balance sheet and solid cash flow, like GoodRx Holdings, Inc., is more likely to weather financial storms, making it a safer investment.

Long-Term Investment Strategy for GoodRx Holdings, Inc.

Investing in GoodRx Holdings, Inc. based on fundamental analysis emphasizes long-term business growth rather than short-term market trends. Investors looking at GoodRx Holdings, Inc. focus on its solid financial performance, industry standing, and competitive advantages, all of which suggest sustainable growth and the potential for steady returns over time.

Fundamental Analysis FAQ

;